Stuttgart - Delayed Quote EUR

Blueprint Medicines Corp (2L9.SG)

Compare
105.50
+2.00
+(1.93%)
As of 9:34:02 PM GMT+1. Market Open.
Loading Chart for 2L9.SG
DELL
  • Previous Close 103.50
  • Open 105.55
  • Bid 105.50 x --
  • Ask 107.90 x --
  • Day's Range 105.40 - 105.75
  • 52 Week Range 66.50 - 111.05
  • Volume 0
  • Avg. Volume 23
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 13, 2025 - Feb 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 2L9.SG

View More

Performance Overview: 2L9.SG

Trailing total returns as of 1/20/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

2L9.SG
24.73%
S&P 500
1.52%

1-Year Return

2L9.SG
46.53%
S&P 500
23.90%

3-Year Return

2L9.SG
63.52%
S&P 500
32.30%

5-Year Return

2L9.SG
47.55%
S&P 500
80.10%

Compare To: 2L9.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2L9.SG

View More

Valuation Measures

As of 1/17/2025
  • Market Cap

    6.79B

  • Enterprise Value

    6.53B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    15.26

  • Price/Book (mrq)

    21.63

  • Enterprise Value/Revenue

    15.49

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 2L9.SG

View More